Related Experiment Videos
Encapsulated cell technology: from research to market
Gorka Orive1, Rosa María Hernández, Alicia R Gascón
1Laboratory of Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy, University of the Basque Country, Vitoria-Gasteiz, Spain.
Trends in Biotechnology
|August 15, 2002
Summary
Encapsulated cell technology offers disease treatment through controlled biological product delivery. Commercialization requires addressing scientific, ethical, regulatory, and market challenges for successful clinical translation.
Area of Science:
- Biotechnology
- Regenerative Medicine
- Drug Delivery Systems
Background:
- Encapsulated cell technology enables sustained delivery of therapeutic biomolecules.
- Promising pre-clinical and clinical data highlight its therapeutic potential.
- Significant commercial interest exists due to potential market applications.
Purpose of the Study:
- To review the potential of encapsulated cell technology for disease treatment.
- To identify key challenges hindering clinical and market translation.
- To provide a comprehensive overview of the field's current status.
Main Methods:
- Literature review of encapsulated cell technology.
- Analysis of pre-clinical and clinical study outcomes.
- Discussion of regulatory, ethical, and market factors.
Main Results:
- Encapsulated cell technology demonstrates efficacy in various disease models.
- Successful translation to market faces hurdles in scientific development.
- Ethical considerations, regulatory pathways, and market dynamics are critical.
Conclusions:
- Encapsulated cell technology holds significant promise for treating diverse diseases.
- Overcoming scientific, ethical, regulatory, and market challenges is crucial for clinical success.
- Further research and strategic planning are needed for therapeutic commercialization.